Belmont Capital LLC raised its stake in shares of The Procter & Gamble Company (NYSE:PG – Free Report) by 42.9% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 28,830 shares of the company’s stock after buying an additional 8,650 shares during the period. Procter & Gamble comprises about 0.8% of Belmont Capital LLC’s investment portfolio, making the stock its 16th biggest holding. Belmont Capital LLC’s holdings in Procter & Gamble were worth $4,993,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds have also modified their holdings of PG. Itau Unibanco Holding S.A. bought a new stake in Procter & Gamble in the second quarter worth approximately $28,000. Fairway Wealth LLC bought a new stake in Procter & Gamble in the second quarter worth $29,000. POM Investment Strategies LLC acquired a new position in Procter & Gamble during the second quarter worth $34,000. Quest Partners LLC bought a new position in Procter & Gamble during the second quarter valued at about $36,000. Finally, Fairfield Financial Advisors LTD acquired a new stake in shares of Procter & Gamble in the second quarter worth about $44,000. 65.77% of the stock is owned by institutional investors and hedge funds.
Insiders Place Their Bets
In other Procter & Gamble news, CEO Ma. Fatima Francisco sold 96,000 shares of Procter & Gamble stock in a transaction on Thursday, August 22nd. The shares were sold at an average price of $170.00, for a total transaction of $16,320,000.00. Following the completion of the sale, the chief executive officer now owns 13,721 shares of the company’s stock, valued at approximately $2,332,570. The trade was a 87.49 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Susan Street Whaley sold 634 shares of the stock in a transaction that occurred on Wednesday, October 2nd. The shares were sold at an average price of $171.65, for a total transaction of $108,826.10. Following the completion of the sale, the insider now owns 19,341 shares in the company, valued at $3,319,882.65. This represents a 3.17 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 270,727 shares of company stock valued at $46,014,037. 0.18% of the stock is currently owned by insiders.
Procter & Gamble Stock Up 0.7 %
Procter & Gamble (NYSE:PG – Get Free Report) last announced its quarterly earnings results on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, beating analysts’ consensus estimates of $1.90 by $0.03. The firm had revenue of $21.74 billion for the quarter, compared to analysts’ expectations of $21.99 billion. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The business’s revenue was down .6% compared to the same quarter last year. During the same period in the prior year, the business posted $1.83 earnings per share. Equities analysts forecast that The Procter & Gamble Company will post 6.94 earnings per share for the current fiscal year.
Procter & Gamble Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were given a $1.0065 dividend. The ex-dividend date of this dividend was Friday, October 18th. This represents a $4.03 dividend on an annualized basis and a yield of 2.36%. Procter & Gamble’s dividend payout ratio (DPR) is presently 69.48%.
Analysts Set New Price Targets
A number of research analysts recently weighed in on the company. TD Cowen assumed coverage on Procter & Gamble in a research note on Tuesday, July 23rd. They issued a “buy” rating and a $189.00 price objective on the stock. DA Davidson boosted their price objective on shares of Procter & Gamble from $159.00 to $160.00 and gave the stock a “neutral” rating in a research note on Monday, October 21st. StockNews.com lowered shares of Procter & Gamble from a “buy” rating to a “hold” rating in a research note on Thursday, August 1st. Stifel Nicolaus boosted their target price on shares of Procter & Gamble from $157.00 to $161.00 and gave the stock a “hold” rating in a research report on Monday, July 22nd. Finally, JPMorgan Chase & Co. raised their price target on Procter & Gamble from $179.00 to $186.00 and gave the company an “overweight” rating in a research report on Thursday, September 19th. Nine research analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $177.00.
View Our Latest Stock Report on Procter & Gamble
Procter & Gamble Company Profile
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Featured Stories
- Five stocks we like better than Procter & Gamble
- Following Congress Stock Trades
- Is Monolithic Power Systems a Screaming Buy After Near 40% Drop?
- Short Selling: How to Short a Stock
- Applied Materials Market Capitulates: Now is the Time to Buy
- Why Invest in 5G? How to Invest in 5G Stocks
- 3 Ultra-High Dividend Yield Stocks for the New Year
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.